SCHEMBL7089153

SCHEMBL7089153

[O]Cc1ccc(OCc2ccccc2)c(S(=O)(=O)c2ccc(F)cc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 2/20 0.46
NFE2L2 Q16236 2/20 0.46
AR P10275 1/20 0.45
LMNA P02545 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
HTT P42858 1/20 0.44
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
MAPT P10636 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
RORC P51449 1/20 0.41
POLB P06746 2/20 0.41
CYP19A1 P11511 2/20 0.41
ALDH1A1 P00352 1/20 0.40
BCL2L1 Q07817 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6852995 0.89 KEAP1 (0.47) KEAP1NFE2L2ARLMNASMN1; SMN2
SCHEMBL6854181 0.83 MAOB (0.48) KEAP1NFE2L2ARLMNASMN1; SMN2
SCHEMBL6849377 0.82 KEAP1 (0.40) KEAP1NFE2L2ARLMNASMN1; SMN2
SCHEMBL6849586 0.81 OPRK1 (0.42) KEAP1NFE2L2ARLMNASMN1; SMN2
SCHEMBL6936062 0.81 KEAP1 (0.40) KEAP1NFE2L2ARLMNASMN1; SMN2
SCHEMBL6856861 0.77 THRB (0.51) KEAP1NFE2L2
SCHEMBL6852831 0.75 KEAP1 (0.36) KEAP1NFE2L2ARLMNASMN1; SMN2
SCHEMBL7751043 0.74 HTR6 (0.49) LMNASMN1; SMN2CA12CA1CA2
SCHEMBL7752409 0.74 CA12 (0.60) ARLMNASMN1; SMN2CA12CA1
SCHEMBL17962403 0.74 ALDH1A1 (0.53) ARLMNASMN1; SMN2HTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030105078-A1 Diphenyl derivatives BAYER AKTIENGESSELLSCHAFT (DE) 2003-06-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030105078-A1 Diphenyl derivatives DPP4, DPP3, DPM1 KEAP1 1863/4885NFE2L2 78/4885AR 1487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.